cholinergic antagonists. anti- muscarinic agents sites of action 1. secretions by salivary,...

34
Cholinergic antagonists

Upload: rosa-lewis

Post on 17-Jan-2016

229 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Cholinergic antagonists

Page 2: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Anti- muscarinic agents

sites of action• 1. Secretions by salivary, bronchial and sweat

glands.• 2. The eye and cardiac responses mediated by

the vagus.• 3. Urinary bladder and GI tract.• 4. Gastric secretions.

Page 3: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Naturally occurring

• Atropine ( belladonna )

• Scopolamine

• Homatropine

Page 4: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

• ATROPINE – high affinity for muscarinic receptors. acts both centrally and peripherally.

• Mydriasis, cycloplegia.• Eneuresis in children• Low doses- bradycardia.• High doses—tachycardia• Dilates cutaneous vasculature

Page 5: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

• Atropine uses• In ophthalmology –mydriatic/ cycloplegic• Spastic disorders of GI and lower urinary tract.• To treat OP poisoning• To suppress respiratory secretions prior to

surgery.

Page 6: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Synthetic quaternary ammonium antimuscarinic agents.

• Ipratropium

• Propantheline

Page 7: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Synthetic tertiary amine muscarinic antagonists

• Cyclopentolate

• Tropicamide

• Dicyclomine

• Pirenzipine

Page 8: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

CNS• Due to its greater lipid solubility, scopolamine

has significant CNS effects even at low therapeutic doses.

• An adjunct for anesthesia due to an ability to decrease short term memory.

• Motion sickness (scopolamine)• Antipsychotic therapy: used to treat the

extrapyramidal symptoms

Page 9: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Eye

• Mydriasis

• Refract the eye during ophthalmic examinations.

• Caution : glaucoma

Page 10: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Heart

• Low doses initially produce bradycardia, but later doses produce tachycardia.

• Some times in Surgery/catheterization

Page 11: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Lung

• Broncho -dilation: Ipratropium• Mainly used as inhalation in treating asthma and

COPD.• Atropine prior to surgery will decrease the

respiratory secretions

Page 12: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

GI tract

• Salivary secretions decrease

• Can cause dry mouth and difficulty in swallowing

• Only Pirenzepine has some potency to decrease hyperacidity..

Page 13: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Other uses

• With an opioid to relax the ureter in renal colic.

• To increase the capacity and decrease the frequency of bladder contractions, i.e.enuresis in children.

• To decrease the frequency of urination in spastic paraplegia.

Page 14: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Toxic effects• decreased concentration and memory• drowsiness• sedation• excitation• ataxia• asynergia• disorientation• hallucinations• coma

Page 15: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

ATROPINE PSYCHOSIS

• Disorientation, confusion, recent loss of memory, agitation, incoherent speech, restlessness, hallucinations, anxiety and delirium.

• Treatment – symptomatic only and discontinue the drug immediately.

Page 16: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Therapeutic uses of muscarinic antagonists

• 1. Premedication• · Atropine• · Given before operations to prevent unwanted M

stimulation.• · Want to eliminate bronchial secretions (don't want the

patient to choke on their own secretions)• · Want to block vagal stimulation to the heart and lungs

(want to keep airways open)• · During induction of anesthesia, there may be excessive

vagal stimulation, which we want to eliminate.

Page 17: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

• Anticholinesterase toxicity• Toxicity due to over dose of physostigmine and

other anticholinesterases

• Atropine is used to treat this condition by blocking all M receptors.

Page 18: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

• 2. Antispasmodic• · Hyoscine N butyl Bromide• · A quaternary derivative• · Treats colic• 3. Bronchodilator (asthma)• · Ipratropium• · A quaternary derivative• · Given by inhalation, get a local effect

Page 19: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

• Homatropine• · Much shorter action than atropine• · It is the drug of choice when doing

investigations of the eye, since it dilates the pupil for a short time only.

Page 20: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

• 4.Treatment of peptic ulcers• · Pirenzepine• · Selective M1 antagonist• · Not as good as H2 antagonists (e.g.

cimetidine) or proton pump inhibitors (e.g. omeprazole)

Page 21: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

• 5. Parkinson's disease • · Benztropine, trihexiphenidyl

also used to treat the extrapyramidal symptoms due to Antipsychotic drugs

• 6. Motion sickness

· Hyoscine, scopolamine

Page 22: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

• REMEMBER • S --- salivation• L --- lacrimation• U --- urination• D --- diaphoresis• G --- GI• E --- Eye & emesis

Page 23: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

GANGLIONIC BLOCKERS

• NICOTINE

• TRIMETHAPHAN

• MECAMYLAMINE

Page 24: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

SITE OF ACTION

• ALL NICOTINIC RECEPTORS

• IN ANS ( BOTH SNS AND PNS )• IN CNS

Page 25: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

NICOTINE

DOSAGE

• LOW DOSE

• HIGH DOSE

GANGLION

• STIMULATION

• BLOCK

Page 26: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

CNS/ NICOTINE

• LOW DOSE- EUPHORIA,RELAXATION

• HIGH DOSE- central respiratory paralysishypotension- medullary paralysis

Page 27: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

PERIPHERAL EFFECTS

• COMPLEX• HR RAISES• B.P.- RAISES• GIT- MOTILITY RAISES

Page 28: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

OTHERS

• TRIMETHAPHAN- SHORT ACTING• HTN EMERGENCIES

• used in surgery, particularly neurosurgery, to produce a relatively bloodless operative field (controlled hypotension).

Page 29: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

• MECAMYLAMINE- LONG ACTINGCHR. CASES of HTN

Page 30: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Neuromuscular Blocking Drugs

Mainly during surgery to produce complete muscle relaxation, without giving higher anesthetic doses.

Page 31: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Neuro muscular blocking drugs• Atracurium• Doxacurium• Mivacurium • Pancuronium• Rocuronium• Succinylcholine• Tubocurarine• Vecuronium

Page 32: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Atracurium• safe in renal failure, used in critically ill patients

for mechanical ventilation. • Short duration of action – so suitable for short

surgical procedures.

Page 33: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Rocuronium & Succinylcholine • Rapid onset of action – so used mainly in

tracheal intubation in patients with gastric contents.

Vecuronium – short duration of action , so used in short surgical procedures.

Page 34: Cholinergic antagonists. Anti- muscarinic agents sites of action 1. Secretions by salivary, bronchial and sweat glands. 2. The eye and cardiac responses

Imp side effects

• Tubocurarine – induce histamine release and also lower B.P.

• Pancuronium – Increased H.R.• Succinylcholine – malignant hyperthermia,

hyperkalemia and increased Intraocular pressure.